These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Blockade of substantia nigra dopamine D1 receptors reduces intravenous cocaine reward in rats. Quinlan MG; Sharf R; Lee DY; Wise RA; Ranaldi R Psychopharmacology (Berl); 2004 Aug; 175(1):53-9. PubMed ID: 14767633 [TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trials of the D1/D5 antagonist ecopipam for weight loss in obese subjects. Astrup A; Greenway FL; Ling W; Pedicone L; Lachowicz J; Strader CD; Kwan R; Obesity (Silver Spring); 2007 Jul; 15(7):1717-31. PubMed ID: 17636090 [TBL] [Abstract][Full Text] [Related]
10. Antagonism of the discriminative stimulus properties of cocaine with the combination of a dopamine D1 and D2 antagonist. Meert TF; De Haes P; Aerts N; Clincke G Acta Neurobiol Exp (Wars); 1996; 56(4):897-905. PubMed ID: 9033125 [TBL] [Abstract][Full Text] [Related]
11. Lethal effects of cocaine are reduced by the dopamine-1 receptor antagonist SCH 23390 but not by haloperidol. Witkin JM; Goldberg SR; Katz JL Life Sci; 1989; 44(18):1285-91. PubMed ID: 2523996 [TBL] [Abstract][Full Text] [Related]
12. Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion. Neisewander JL; Fuchs RA; O'Dell LE; Khroyan TV Synapse; 1998 Oct; 30(2):194-204. PubMed ID: 9723789 [TBL] [Abstract][Full Text] [Related]
13. Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study. Gilbert DL; Murphy TK; Jankovic J; Budman CL; Black KJ; Kurlan RM; Coffman KA; McCracken JT; Juncos J; Grant JE; Chipkin RE Mov Disord; 2018 Aug; 33(8):1272-1280. PubMed ID: 30192018 [TBL] [Abstract][Full Text] [Related]
14. Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates. Khroyan TV; Platt DM; Rowlett JK; Spealman RD Psychopharmacology (Berl); 2003 Jul; 168(1-2):124-131. PubMed ID: 12607074 [TBL] [Abstract][Full Text] [Related]
15. Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists. Reeves R; Thiruchelvam M; Cory-Slechta DA Brain Res; 2004 May; 1008(2):155-67. PubMed ID: 15145752 [TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. White FJ; Joshi A; Koeltzow TE; Hu XT Neuropsychopharmacology; 1998 Jan; 18(1):26-40. PubMed ID: 9408916 [TBL] [Abstract][Full Text] [Related]
17. Microinjections of a dopamine D1 receptor antagonist into the ventral tegmental area block the expression of cocaine conditioned place preference in rats. Galaj E; Manuszak M; Arastehmanesh D; Ranaldi R Behav Brain Res; 2014 Oct; 272():279-85. PubMed ID: 25017572 [TBL] [Abstract][Full Text] [Related]
18. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Caine SB; Heinrichs SC; Coffin VL; Koob GF Brain Res; 1995 Sep; 692(1-2):47-56. PubMed ID: 8548319 [TBL] [Abstract][Full Text] [Related]